<p>Modeled mean pVL (A) and CD4 cell count (B) over time after randomization/TI in the no treatment and the 24- and 60-wk treatment arms for the group of patients randomized over the three study arms. Graphs show the estimates (± standard error of the mean) from the linear mixed models. The box below each graph shows the number of pVL and CD4 cell count measurements at each time point used for fitting the linear mixed models. c/ml, copies/ml.</p
(See the editorial commentary by Maggiolo and Leone, on pages 465–467.) Background. Although the kin...
<p>Median CD4 cell counts (cells/mm<sup>3</sup>) from baseline at down-referral to 48 months in the ...
<p>a, the reverse association of CD4+ T-cell counts and viral loads in the study subjects at baselin...
<p>(A) Calculation of the set-point viral load and CD4+ T-cell decline, illustrated for a single ind...
<p>Estimated CD4 cell count dynamics in viremic patients (VIRs: n = 478) and elite controllers (ECs:...
<p>Baseline CD4 counts and viral load (VL) over time are taken to reflect the baseline status of the...
<p>Clinical parameters, average CD4 and viral load (VL) were generated from across the entire study ...
<p>For each sex and age grouping, these panels show estimated asymptotic CD4+ count versus estimated...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
<p>Number of viral load and CD4<sup>+</sup> T-cell count measurements at different points in time in...
<p>Plasma viral load (pVl) is shown as Log10 HIV-1 RNA copies/ml. CD4+ T-cell count is shown as cell...
<p>Viral load (triangles; 46731 and 41023 viral RNA copy/ml of plasma), absolute CD4<sup>+</sup> T-c...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
<p>Elite controllers (panels a and b) and rapid progressors (panels c and d). Each dot represents da...
<p>CD4 slopes were computed by multilevel regression modelling of six-monthly retrospective particip...
(See the editorial commentary by Maggiolo and Leone, on pages 465–467.) Background. Although the kin...
<p>Median CD4 cell counts (cells/mm<sup>3</sup>) from baseline at down-referral to 48 months in the ...
<p>a, the reverse association of CD4+ T-cell counts and viral loads in the study subjects at baselin...
<p>(A) Calculation of the set-point viral load and CD4+ T-cell decline, illustrated for a single ind...
<p>Estimated CD4 cell count dynamics in viremic patients (VIRs: n = 478) and elite controllers (ECs:...
<p>Baseline CD4 counts and viral load (VL) over time are taken to reflect the baseline status of the...
<p>Clinical parameters, average CD4 and viral load (VL) were generated from across the entire study ...
<p>For each sex and age grouping, these panels show estimated asymptotic CD4+ count versus estimated...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
<p>Number of viral load and CD4<sup>+</sup> T-cell count measurements at different points in time in...
<p>Plasma viral load (pVl) is shown as Log10 HIV-1 RNA copies/ml. CD4+ T-cell count is shown as cell...
<p>Viral load (triangles; 46731 and 41023 viral RNA copy/ml of plasma), absolute CD4<sup>+</sup> T-c...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
<p>Elite controllers (panels a and b) and rapid progressors (panels c and d). Each dot represents da...
<p>CD4 slopes were computed by multilevel regression modelling of six-monthly retrospective particip...
(See the editorial commentary by Maggiolo and Leone, on pages 465–467.) Background. Although the kin...
<p>Median CD4 cell counts (cells/mm<sup>3</sup>) from baseline at down-referral to 48 months in the ...
<p>a, the reverse association of CD4+ T-cell counts and viral loads in the study subjects at baselin...